+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

BRIC Metabolic Disorders Market Outlook to 2036 - Diabetes Assays and Cholesterol Tests

  • PDF Icon

    Report

  • 114 Pages
  • May 2026
  • Region: Brazil, China, India, Russia
  • GlobalData
  • ID: 6115327

BRIC Metabolic Disorders Market Outlook to 2036 - Diabetes Assays and Cholesterol Tests

Summary

The analyst’s “BRIC Metabolic Disorders Market Outlook to 2036” is a comprehensive databook report, covering key market data on the BRIC Metabolic Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Diabetes Assays, Cholesterol Tests

The BRIC Metabolic Disorders Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Metabolic Disorders Market.
  • Global corporate-level profiles of key companies operating within the BRIC Metabolic Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

BRIC Metabolic Disorders is segmented as follows:

  • Diabetes Assays
  • Cholesterol Tests

Reasons to Buy

The BRIC Metabolic Disorders Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Metabolic Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Metabolic Disorders Market, BRIC
2.1 Metabolic Disorders Market, BRIC, Revenue ($m), 2024-2036
2.2 Metabolic Disorders Market, BRIC, Revenue ($m), 2024-2036
2.3 Metabolic Disorders Market, BRIC, Volume (Units), 2024-2036
2.4 Metabolic Disorders Market, BRIC, Volume (Units), 2024-2036
2.5 Metabolic Disorders Market, BRIC, Company Share by Revenue ($m), 2025
3 Metabolic Disorders Market, Brazil
3.1 Metabolic Disorders Market, Brazil, Revenue ($m), 2024-2036
3.1.1 Cholesterol Tests Market, Brazil, Revenue ($m), by Segment, 2024-2036
3.1.2 Diabetes Assays Market, Brazil, Revenue ($m), by Segment, 2024-2036
3.2 Metabolic Disorders Market, Brazil, Volume (Units), 2024-2036
3.2.1 Cholesterol Tests Market, Brazil, Volume (Units), by Segment, 2024-2036
3.2.2 Diabetes Assays Market, Brazil, Volume (Units), by Segment, 2024-2036
3.3 Metabolic Disorders Market, Brazil, Average Price ($), 2024-2036
3.4 Metabolic Disorders Market, Brazil, Company Share by Revenue ($m), 2025
4 Metabolic Disorders Market, China
4.1 Metabolic Disorders Market, China, Revenue ($m), 2024-2036
4.1.1 Cholesterol Tests Market, China, Revenue ($m), by Segment, 2024-2036
4.1.2 Diabetes Assays Market, China, Revenue ($m), by Segment, 2024-2036
4.2 Metabolic Disorders Market, China, Volume (Units), 2024-2036
4.2.1 Cholesterol Tests Market, China, Volume (Units), by Segment, 2024-2036
4.2.2 Diabetes Assays Market, China, Volume (Units), by Segment, 2024-2036
4.3 Metabolic Disorders Market, China, Average Price ($), 2024-2036
4.4 Metabolic Disorders Market, China, Company Share by Revenue ($m), 2025
5 Metabolic Disorders Market, India
5.1 Metabolic Disorders Market, India, Revenue ($m), 2024-2036
5.1.1 Cholesterol Tests Market, India, Revenue ($m), by Segment, 2024-2036
5.1.2 Diabetes Assays Market, India, Revenue ($m), by Segment, 2024-2036
5.2 Metabolic Disorders Market, India, Volume (Units), 2024-2036
5.2.1 Cholesterol Tests Market, India, Volume (Units), by Segment, 2024-2036
5.2.2 Diabetes Assays Market, India, Volume (Units), by Segment, 2024-2036
5.3 Metabolic Disorders Market, India, Average Price ($), 2024-2036
5.4 Metabolic Disorders Market, India, Company Share by Revenue ($m), 2025
6 Metabolic Disorders Market, Russia
6.1 Metabolic Disorders Market, Russia, Revenue ($m), 2024-2036
6.1.1 Cholesterol Tests Market, Russia, Revenue ($m), by Segment, 2024-2036
6.1.2 Diabetes Assays Market, Russia, Revenue ($m), by Segment, 2024-2036
6.2 Metabolic Disorders Market, Russia, Volume (Units), 2024-2036
6.2.1 Cholesterol Tests Market, Russia, Volume (Units), by Segment, 2024-2036
6.2.2 Diabetes Assays Market, Russia, Volume (Units), by Segment, 2024-2036
6.3 Metabolic Disorders Market, Russia, Average Price ($), 2024-2036
6.4 Metabolic Disorders Market, Russia, Company Share by Revenue ($m), 2025
7 Metabolic Disorders Market Pipeline Products
7.1 Metabolic Disorders Market Pipeline Products
7.2 Metabolic Disorders - Pipeline Products by Stage of Development
7.3 Metabolic Disorders - Pipeline Products by Segment
7.4 Metabolic Disorders - Pipeline Products by Territory
7.5 Metabolic Disorders - Pipeline Products by Regulatory Path
7.6 Metabolic Disorders - Pipeline Products by Estimated Approval Date
8 Overview of Key Companies in BRIC Metabolic Disorders Market
8.1 Roche Diagnostics International Ltd
8.1.1 Company Overview
8.2 Siemens Healthineers AG
8.2.1 Company Overview
8.3 Abbott Laboratories
8.3.1 Company Overview
8.4 Beckman Coulter Inc
8.4.1 Company Overview
8.5 Thermo Fisher Scientific Inc Error! Bookmark not defined.
8.5.1 Company Overview Error! Bookmark not defined.
8.6 Ortho Clinical Diagnostics Holdings Ltd (Inactive) Error! Bookmark not defined.
8.6.1 Company Overview Error! Bookmark not defined.
8.7 Sekisui Diagnostics LLC Error! Bookmark not defined.
8.7.1 Company Overview Error! Bookmark not defined.
8.8 Sinocare Inc Error! Bookmark not defined.
8.8.1 Company Overview Error! Bookmark not defined.
8.9 Randox Laboratories Ltd Error! Bookmark not defined.
8.9.1 Company Overview Error! Bookmark not defined.
8.10 Danaher Corp Error! Bookmark not defined.
8.10.1 Company Overview Error! Bookmark not defined.
8.11 Bio-Rad Laboratories Inc Error! Bookmark not defined.
8.11.1 Company Overview Error! Bookmark not defined.
8.12 Quidel Corp Error! Bookmark not defined.
8.12.1 Company Overview Error! Bookmark not defined.
8.13 EKF-diagnostic GmbH Error! Bookmark not defined.
8.13.1 Company Overview Error! Bookmark not defined.
8.14 Tosoh Bioscience Inc Error! Bookmark not defined.
8.14.1 Company Overview Error! Bookmark not defined.
8.15 Helena Laboratories Corp Error! Bookmark not defined.
8.15.1 Company Overview Error! Bookmark not defined.
9 Appendix
9.1 Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the Analyst Consulting
9.3 Contact Us
9.4 Disclaimer
List of Tables
Table 1: Metabolic Disorders Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2024-2036
Table 2: Metabolic Disorders Market, BRIC, Revenue ($m), USD Constant, 2024-2036
Table 3: Metabolic Disorders Market, BRIC, Volume (Units), 2024-2036
Table 4: Metabolic Disorders Market, BRIC, Volume (Units), 2024-2036
Table 5: Metabolic Disorders Market, BRIC, Company Share by Revenue ($m), 2025
Table 6: Metabolic Disorders Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Table 7: Cholesterol Tests Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Table 8: Diabetes Assays Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Table 9: Metabolic Disorders Market, Brazil, Volume (Units), 2024-2036
Table 10: Cholesterol Tests Market, Brazil, Volume (Units), 2024-2036
Table 11: Diabetes Assays Market, Brazil, Volume (Units), 2024-2036
Table 12: Metabolic Disorders Market, Brazil, Average Price ($), 2024-2036
Table 13: Metabolic Disorders Market, Brazil, Company Share by Revenue ($m), USD Constant, 2025
Table 14: Metabolic Disorders Market, China, Revenue ($m), USD Constant, 2024-2036
Table 15: Cholesterol Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Table 16: Diabetes Assays Market, China, Revenue ($m), USD Constant, 2024-2036
Table 17: Metabolic Disorders Market, China, Volume (Units), 2024-2036
Table 18: Cholesterol Tests Market, China, Volume (Units), 2024-2036
Table 19: Diabetes Assays Market, China, Volume (Units), 2024-2036
Table 20: Metabolic Disorders Market, China, Average Price ($), 2024-2036
Table 21: Metabolic Disorders Market, China, Company Share by Revenue ($m), USD Constant, 2025
Table 22: Metabolic Disorders Market, India, Revenue ($m), USD Constant, 2024-2036
Table 23: Cholesterol Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Table 24: Diabetes Assays Market, India, Revenue ($m), USD Constant, 2024-2036
Table 25: Metabolic Disorders Market, India, Volume (Units), 2024-2036
Table 26: Cholesterol Tests Market, India, Volume (Units), 2024-2036
Table 27: Diabetes Assays Market, India, Volume (Units), 2024-2036
Table 28: Metabolic Disorders Market, India, Average Price ($), 2024-2036
Table 29: Metabolic Disorders Market, India, Company Share by Revenue ($m), USD Constant, 2025
Table 30: Metabolic Disorders Market, Russia, Revenue ($m), USD Constant, 2024-2036
Table 31: Cholesterol Tests Market, Russia, Revenue ($m), USD Constant, 2024-2036
Table 32: Diabetes Assays Market, Russia, Revenue ($m), USD Constant, 2024-2036
Table 33: Metabolic Disorders Market, Russia, Volume (Units), 2024-2036
Table 34: Cholesterol Tests Market, Russia, Volume (Units), 2024-2036
Table 35: Diabetes Assays Market, Russia, Volume (Units), 2024-2036
Table 36: Metabolic Disorders Market, Russia, Average Price ($), 2024-2036
Table 37: Metabolic Disorders Market, Russia, Company Share by Revenue ($m), USD Constant, 2025
Table 38: Metabolic Disorders Market Pipeline Products
Table 39: Metabolic Disorders - Pipeline Products by Stage of Development
Table 40: Metabolic Disorders Companies - Pipeline Products by Stage of Development
Table 41: Metabolic Disorders - Pipeline Products by Segment
Table 42: Metabolic Disorders - Pipeline Products by Territory
Table 43: Metabolic Disorders - Pipeline Products by Regulatory Path
Table 44: Metabolic Disorders - Pipeline Products by Estimated Approval Date
Table 45: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Metabolic Disorders Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2024-2036
Figure 2: Metabolic Disorders Market, BRIC, Revenue ($m), USD Constant, 2024-2036
Figure 3: Metabolic Disorders Market, BRIC, Volume (Units), 2024-2036
Figure 4: Metabolic Disorders Market, BRIC, Volume (Units), 2024-2036
Figure 5: Metabolic Disorders Market, BRIC, Company Share (%), 2025
Figure 6: Metabolic Disorders Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Figure 7: Cholesterol Tests Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Figure 8: Diabetes Assays Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Figure 9: Metabolic Disorders Market, Brazil, Volume (Units), 2024-2036
Figure 10: Cholesterol Tests Market, Brazil, Volume (Units), 2024-2036
Figure 11: Diabetes Assays Market, Brazil, Volume (Units), 2024-2036
Figure 12: Metabolic Disorders Market, Brazil, Company Share (%), 2025
Figure 13: Metabolic Disorders Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 14: Cholesterol Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 15: Diabetes Assays Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 16: Metabolic Disorders Market, China, Volume (Units), 2024-2036
Figure 17: Cholesterol Tests Market, China, Volume (Units), 2024-2036
Figure 18: Diabetes Assays Market, China, Volume (Units), 2024-2036
Figure 19: Metabolic Disorders Market, China, Company Share (%), 2025
Figure 20: Metabolic Disorders Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 21: Cholesterol Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 22: Diabetes Assays Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 23: Metabolic Disorders Market, India, Volume (Units), 2024-2036
Figure 24: Cholesterol Tests Market, India, Volume (Units), 2024-2036
Figure 25: Diabetes Assays Market, India, Volume (Units), 2024-2036
Figure 26: Metabolic Disorders Market, India, Company Share (%), 2025
Figure 27: Metabolic Disorders Market, Russia, Revenue ($m), USD Constant, 2024-2036
Figure 28: Cholesterol Tests Market, Russia, Revenue ($m), USD Constant, 2024-2036
Figure 29: Diabetes Assays Market, Russia, Revenue ($m), USD Constant, 2024-2036
Figure 30: Metabolic Disorders Market, Russia, Volume (Units), 2024-2036
Figure 31: Cholesterol Tests Market, Russia, Volume (Units), 2024-2036
Figure 32: Diabetes Assays Market, Russia, Volume (Units), 2024-2036
Figure 33: Metabolic Disorders Market, Russia, Company Share (%), 2025
Figure 34: Metabolic Disorders - Pipeline Products by Stage of Development
Figure 35: Metabolic Disorders - Pipeline Products by Segment
Figure 36: Metabolic Disorders - Pipeline Products by Territory
Figure 37: Metabolic Disorders - Pipeline Products by Regulatory Path
Figure 38: Metabolic Disorders - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Roche Diagnostics International Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Beckman Coulter Inc